ClinicalTrials.Veeva

Menu

Vitamin D Levels and Survival in Cancer Patients

I

Icelandic Heart Association

Status

Completed

Conditions

Neoplasms

Study type

Observational

Funder types

Other

Identifiers

NCT03266887
HI14010102

Details and patient eligibility

About

Using the population-based data sources in Iceland and the well-characterized AGES-Reykjavik cohort, our overarching aims are on exploring whether pre-diagnostic serum levels of 25-hydroxyvitamin D (25(OH)D) among older individuals living in Iceland were associated with survival after cancer diagnosis. We also wanted to assess the risk of being diagnosed with cancer in association with 25(OH)D levels. In this population living just south of the arctic circle, vitamin D levels largely depend on dietary- and supplemental sources.

Enrollment

5,764 patients

Sex

All

Ages

66 to 98 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

To be part of the AGES-Reykjavik Study, initiated between 2002 and 2006.

Exclusion criteria

Diagnosed with cancer at study entry

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems